Recent research from Italy shows promise for people afflicted with mesothelioma.
In a study, a 49-year-old woman with mesothelioma found relief through a medical treatment called laparoscopic hyperthermic intraperitoneal chemotherapy (LHIPEC). In the study, ascites, which is an accumulation of fluid in the peritoneal cavity, were dramatically reduced from within the woman’s abdomen.
Following the procedure, the woman experienced complete abdominal symptom relief. In fact, ascites did not even recur during a follow-up period of six months.
Researchers believe LHIPEC has the potential to be a great therapeutic option to palliate malignant peritoneal mesothelioma.
The fact that positive results have been concluded is outstanding for both future and present patients dealing with mesothelioma. If further testing on laparoscopic hyperthermic intraperitoneal chemotherapy continues to promote positive results, it could eventually become a great therapeutic tool for patients when other medical therapies have already failed.
Mesothelioma is typically caused by asbestos exposure either in the workplace like shipyards and smelters, or through second-hand exposure to asbestos brought home from toxic workplaces. Despite the success of this experimental procedure, there is no know cure and mesothelioma is almost always fatal.
G.P.S. divx If you or a loved one has been diagnosed with this painful disease, it is in your best interest to contact an experienced mesothelioma attorney for professional insight into developing an asbestos lawsuit.